PLXP PLx Pharma Inc.

3.82
-0.02  -1%
Previous Close 3.84
Open 3.82
Price To Book 9.8
Market Cap 33394960
Shares 8,742,136
Volume 180
Short Ratio
Av. Daily Volume 3,285

SEC filingsSee all SEC filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181171425
  2. 8-K - Current report 181077877
  3. 8-K - Current report 181050312
  4. DEF 14A - Other definitive proxy statements 181007706
  5. 8-K - Current report 181007297

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 top-line data did not meet endpoints - October 25, 2016.
Locilex
Mild infections of diabetic foot ulcers
sNDA filing for 81mg dose has been delayed - noted March 23, 2018. To be filed late likely late 2019.
Aspertec
Aspirin - cardiovascular and stroke patients patients

SEC Filings

  1. 10-Q - Quarterly report [Sections 13 or 15(d)] 181171425
  2. 8-K - Current report 181077877
  3. 8-K - Current report 181050312
  4. DEF 14A - Other definitive proxy statements 181007706
  5. 8-K - Current report 181007297
  6. 10-Q - Quarterly report [Sections 13 or 15(d)] 181007084
  7. 8-K - Current report 18995300
  8. 10-Q - Quarterly report [Sections 13 or 15(d)] 18824917
  9. 10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405] 18785257
  10. 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] 18708396